medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 609

<< Back Next >>

Rev Med Cos Cen 2014; 71 (609)

Neoplasia endocrina múltiple tipo 1

González LEA, Mora HGA
Full text How to cite this article

Language: Spanish
References: 10
Page: 29-33
PDF size: 166.03 Kb.


Key words:

No keywords

ABSTRACT

The term Multiple Endocrine Neoplasia (MEN), was implemented in 1968. It refers to a disorder with synchronous or metachronous neoplasms in two or more different endocrine organs. It may occur sporadically or hereditary, in the last case usually occurs in several members of a family for generations. MEN is divided into several types, the most prevalent are types 1 and 2, (10) type 2 was sub classified into 2A and 2B in 1975. (5) Currently there are genetic methods that allow identifying existing mutations and this can better determine its diagnosis, prognosis and treatment.


REFERENCES

  1. Akertrom, G; Stálberg, P. Surgical Management of MEN 1 an 2: State of the Art. Surgical Clinics North America. 2009. Vol. 89: 1047-1068.

  2. Boudreaux, J. Surgery for Gastroenteropancreatic Neuroendocrine Tumors (GEPNETS). Endocrinology Metabolic Clinics North America 2011. Vol. 40:163-171.

  3. Callender, G; Rich, T; Perrier, N. Multiple Endocrine Neoplasia Syndromes. Surgical Clinics of North American 2008. Vol. 88: 863- 895.

  4. Larrandaburu, M et al. Neoplasia Endocrina Múltiple. Presentación de GONZÁLEZ, MORA: NEOPLASIA ENDOCRINA MÚLTIPLE TIPO 1 33 una familia afectada con diagnostic molecular. Revista Médica Uruguaya. 2008. Vol 24: 203-211.

  5. Richards, M. Thyroid Cancer Genetics: Multiple Endocrine Neoplasia Type 2, Non-Medullary Familial Thyroid Cancer, and Familial syndromes Associated with Thyroid Cancer. Surgical Oncology Clinics of North America. 2008. Vol. 18: 39-52.

  6. Rubinstein, W. Endocrine Cancer Predisposition Syndromes: Hereditary Paraganglioma, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2, and Hereditary Thyroid Cancer. Hematologic Oncology Clinical of North America 2010. Vol. 24: 907- 937.

  7. Sarvida, M; O´Dorisio, M. Neuroendocrine Tumors in Children and Young Adults: Rare or not so Rare. Endocrinology Metabolic Clinics of North America 2011. Vol40: 65-80.

  8. Thakker, R. Multiple endocrine neoplasia type 1 (MEN1). Best Practice & Research Clinical Endocrinology & Metabolism 2010. Vol. 24: 355-370.

  9. Vinik, A; Gonzalez, R. New and Emerging Syndromes due to Neuroendocrine Tumors. Endocrinology Metabolic Clinics North America 2011. Vol. 40: 19-63.

  10. White, M; Doherty, G. Multiple Endocrine Neoplasia. Surgical Oncology Clinics of North America, 2008. Vol. 18. Pag 439-459.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2014;71